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a b s t r a c t
Nuclear receptors (NRs) have recently received much attention for their newly discovered roles in T cell de-
velopment, as exempliﬁed by RARα (Treg cells) and RORγt (Th17 cells). In previous studies, we characterized
a new type of T cell subset, designated as Tchreg (cytotoxic, helper, and regulatory T) cells, in terms of its
cytokine signature. In this study, we investigated the expression and functional relevance of NRs in Tchreg
cells by performing mRNA proﬁling of HOZOT, a cord blood-derived Tchreg cell line. We identiﬁed eleven
inducible and eight constitutively expressed NRs in HOZOT. Among these NRs, RXRα and PPARγ showed
features of signature NRs of Tchreg cells because they were selectively expressed in HOZOT compared with
other T cell subsets. These NRs exhibited contrasting expression patterns, as RXRα was independent of
anti-CD3/28 antibody stimulation while PPARγ was stimulated-dependent. Upon agonist treatment, both
proteins translocated to the nucleus and inhibited IFN-γ production through binding to the promoter region
of the IFN-γ gene. These results provide new insight into the roles of RXRα and PPARγ in T cell biology,
especially in their biological relevance in Tchreg cells.
c© 2012 Elsevier B.V.
1. Introduction
Nuclear receptors (NRs) are ligand-activated transcription factors
that modulate gene expression through binding to speciﬁc hormone
response elements. A total of forty-eight human NRs have been iden-
tiﬁed and classiﬁed into seven groups: the thyroid hormone receptor
family, the retinoid X receptor family, the estrogen receptor family,
the neuron growth factor IB family, the steroid family, the germ cell
nuclear factor, and others [1]. Since NRs function as transcription fac-
tors, their roles include diverse physiological and pathological pro-
cesses such as cellular development and differentiation, metabolic
homeostasis, cancer, autoimmune diseases, inﬂammatory diseases,
and diabetes [2,3].
Studies of NRs have recently focused on T cell biology. Naı¨ve CD4+
T cells differentiate into distinct types of T cells under the appro-
priate inducing conditions. Among them, T helper (Th) 17, a sub-
set of T helper cells characterized by secretion of Interleukin (IL)-17,
have been associated with the pathogenesis of autoimmunity [4–
6] and their development was linked to the expression of retinoic
acid-related orphan receptor (ROR) γt [7]. Under Th17 differentia-
tion conditions, IL-6 and transforming growth factor (TGF)-β induce
* Corresponding author. Tel.: +81 86 276 8621; fax: +81 86 274 2150.
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the expression of RORγt, which directly or indirectly promotes IL-
17 transcription. However, it is not yet known whether this process
is ligand-dependent. Regulatory T (Treg) cells are another example
of NR-controlled T cells. Forkhead-winged helix family transcription
factor 3+ Treg cells are induced in a manner reciprocal to Th17 cells
by IL-2 and TGF-β, and a retinoic acid receptor (RAR) ligand such as
retinoic acid can enhance their differentiation [8]. Tr1 cells (an IL-10-
producing type of Treg cell), are induced by an active form of vitamin
D3 [9]. Interestingly, retinoic acid promotes Treg cell differentiation
in the intestine whereas vitamin D3 does the same in the skin, high-
lighting specialized roles for nuclear receptor ligands in local tissues.
In previous studies, we described a new and distinct type of
Treg cell line, termed HOZOT [10]. HOZOT exhibited multifunctional
properties such as suppression of mixed lymphocyte reaction (MLR),
helper activity under anti-CD3 stimulation conditions, cytotoxic ac-
tivity and cell-in-cell activity against human tumor cells [10–13].
Therefore, we designated these cells as Tchreg (cytotoxic, helper,
and regulatory) cells. By mRNA proﬁling, cytokines and chemokines
such as IFN-γ, IL-10, RANTES, and IL-8 were identiﬁed as signature
molecules of Tchreg cells [14,15]. We also reported the low expres-
sion of micro RNA (miR)-155 as a characteristic of Tchreg cells, in
contrast to the high miR-155 expression levels observed in natural
Treg cells [16]. Since NRs play important roles in T cell development
and function, we focused this study on the biological relevance of NR
2211-2839 c© 2012 Elsevier B.V.
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Fig. 1. RXRA and PPARG were deﬁned as signature NRs by comparing their expression in HOZOTs to those in other T cell subsets. Expression of RXRA (A) or PPARG (B) mRNA in T
cell subsets is shown as a ratio of RXRA or PPARG mRNA to 18 S rRNA, respectively. RNA was harvested after 24h culture with or without anti-CD3/28 antibody stimulation, and
the relative amount of mRNA was measured by RT-qPCR. All values were standardized by deﬁning the sample value of the anti-CD3/28 antibody stimulated HOZOT (#4) as 1.0.
Results of two independent experiments are presented as experiment 1 (left) and 2 (right).
expression and function in Tchreg cells. To accomplish this, we ﬁrst
examined mRNA expression of NRs in HOZOT using DNA microarray
analysis and identiﬁed retinoid X receptorα (RXRα) and peroxisome
proliferator-activated receptor (PPAR)γ as signature NRs. We further
investigated the effects of agonistic ligands of these NRs on protein
localization and cytokine production.
2. Materials and methods
2.1. Reagents
Interleukin (IL)-2 was purchased from Pepro Tech EC Ltd. (Lon-
don, UK). Anti-CD3ε (UCHT-1), anti-CD28 (37407) antibodies, and
RANTES ELISA kits were purchased from R&D Systems (Minneapo-
lis, MN, USA). IL-10 ELISA kits were purchased from eBioscience (San
Diego, CA, USA). IFN-γ ELISA kit was obtained from Hayashibara Bio-
chemical Labs. (Okayama, Japan). Anti-PPARγ (E-8), either Alexa 488-
conjugatedorunconjugated, andanti-humanRXRα (D-20) antibodies
were purchased from Santa Cruz Biosciences (Santa Cruz, CA, USA).
Ligands for NRs were obtained as follows: thiazolidinedione (TZD)
and GW9662 were purchased from WAKO chemical (Osaka, Japan)
and Calbiochem (San Diego, CA), respectively. NEt-3IP (RXR speciﬁc
agonist) and NS-4TF (RXR antagonist) were synthesized as described
in the previous reports [17–19].
2.2. Generation of HOZOT cells
The generation of HOZOT cell lines was described in detail previ-
ously [10]. Brieﬂy, umbilical cord blood (UCB) samples were collected
at Kurashiki Medical Center after obtaining informed consent accord-
ing to the Declaration of Helsinki. Mononuclear cells (MNC) derived
from UCB were enriched using Ficoll-paque density centrifugation
and co-cultured with mouse stromal cell lines, ST2 or MS-5, in RPMI-
1640 medium containing 10% fetal bovine serum (FBS). Two to three
weeks later, proliferative cells, which exhibited cytotoxicity against
the stromal cell line, were expanded in the presence of IL-2 (10ng/
mL). The expanded cells, termed HOZOT, were used for further anal-
ysis.
2.3. Cell preparation
Thepreparationof conventional T (ConT) cells andnaturally occur-
ring T regulatory (nTreg) cells was described previously. UCB-derived
CD25+ cells were isolated by positive selection with directly conju-
gated anti-CD25 magnetic beads (Militenyi Biotech, Bergisch Glad-
bach, Germany). The purity of CD25+ cells were >90%. CD25+ T cells
were used for the preparation of nTreg cells. CD25− cells were treated
with anti-CD4 magnetic beads (Militenyi Biotech), and CD4+ cells
were enrichedusing theMidi-MACS system. Thepurity of CD4+CD25−
cells were >95%. CD4+CD25− T cells were used for the preparation of
ConT cells. CD25+ T cells and CD4+CD25− T cells were stimulated on
plates coated with anti-CD3/CD28 antibodies in RPMI-1640 medium
containing 10% FBS at 37 ◦C in 5% CO2 in the presence of 10ng/mL
IL-2. Growing cells were used as nTreg and ConT cells.
2.4. DNA microarray analysis
Preparation of DNAmicroarray samples was described previously
[15]. Total RNA from HOZOT was isolated with RNeasy kit (Quiagen,
Valencia, USA) according to themanufacturer’s instructions. The sam-
pleswere processed and analyzed at the BioMatrix Research Institute
(Nagareyama, Chiba, Japan) using U133 Plus 2.0 Affymetrix Gene Chip
arrays containing 54,675 human genes and transcripts. DNAmicroar-
ray data of HOZOT were normalized and analyzed by Gene Spring GX
software (Agilent Technologies, Wilmington, DE, USA).
2.5. Real-time quantitative polymerase chain reaction (RT-qPCR)
The expression of NRs was analyzed at the mRNA level by RT-
qPCR. Total RNAwas isolated fromHOZOT, ConT cells, nTreg cells and
CD4+CD25− T cells using RNeasy kit (Qiagen). RT-qPCR was done as
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Fig. 2. Time course study showed RXRA as a constitutively expressed gene and PPARG as an inducible gene. (A) The time course of RXRA or PPARG mRNA expression by HOZOT
cells was analyzed. The amount of RXRA or PPARG mRNA in 0, 1.5, 3, 6, and 24h culture samples was measured by RT-qPCR. The ratios of RXRA or PPARG mRNA to 18 S rRNA are
shown after standardization as in Fig. 1. (B) The time course of RXRα or PPARγ protein expression was studied. RXRα or PPARγ protein in 0, 1.5, 3, 6, and 24h culture samples
was detected by Western blotting using anti-RXRα or anti-PPARγ antibody. After stripping, the membrane was reprobed with anti-β-actin antibody. The optical density ratios
of RXRα or PPARγ bands relative to a corresponding β-actin band are shown for quantitative analysis. The values are shown as the means± SD of three experiments. * and **;
p<0.05 and p<0.01 compared with the values of the control without antibody stimulation, respectively.
described previously [15]. The primer sequences used in this study
are described elsewhere (Suppl. Fig. 1).
2.6. Immunohistochemistry
Cells were cytospun onto slide glasses and ﬁxed with ice-cold
methanol for 2min. After treatment with blocking buffer containing
1% FBS in PBS, RXRα proteins were stained using an anti-RXRα anti-
body and Alexa 488-conjugated anti-rabbit IgG antibody, and PPARγ
was stained with Alexa 488-conjugated anti-PPARγ antibody. The
nuclei were counterstained with 0.5μg/mL Hoechst 33258 in PBS.
2.7. Western blotting analysis
Western blotting was performed as previously described [20].
Brieﬂy, equivalent amounts of total protein were loaded onto 10%
SDS polyacrylamide gels. After electrophoresis, proteins were elec-
trotransferred onto the nitrocellulose membranes and reacted with
the appropriate primary antibody according to standard methods.
Bound immunocomplexes were visualized by use of Super Signal
West Pico (Pierce, Rockford, IL). In some experiments, themembranes
were strippedand then reprobedwithanti-acetyl histoneH3antibody
(Millipore International, Inc., Temecula, CA) or anti-β-actin antibody
to conﬁrm the equality of total nuclear or cytoplasmic protein loading.
2.8. Cytokine production assays
Six-well ﬂat-bottom plates were precoated with anti-CD3 (1μg/
mL) and anti-CD28 (1μg/mL) antibodies. HOZOT cells were cultured
in the six-well ﬂat-bottomplates at 1×106/well/mLfor16h, inRPMI-
1640 medium containing 10% FBS and 10ng/mL IL-2. HOZOT cells
were collected and washed with RPMI-1640 medium containing 10%
FBS and resuspended in the samemedium.HOZOT cellswere cultured
in 24-well ﬂat-bottomplates,whichwere coatedwith anti-CD3/CD28
(1μg/mL) antibody at 5×105/well for one day with or without in-
creasing concentrations of TZD, NEt-3IP, GW9662, and NS-4TF, each
alone or in combination. Cell culture supernatants were harvested
and analyzed for IFN-γ, RANTES and IL-10 production using ELISA
kits.
2.9. Chromatin immunoprecipitation (ChIP) assays
Chromatin immunoprecipitationwas performed as previously de-
scribed [14]. Brieﬂy, HOZOT cells were ﬁxed with 1% formaldehyde
for 10min at room temperature, and then the ﬁxation was stopped
with 1.25M glycine. Fixed cells were washed with cold PBS. Cells
were treated with lysis buffer (Santa Cruz Biotechnology) and son-
icated six times (10 s each) to prepare chromatin extracts. Protein
G beads (100μL) were incubated with anti-PPARγ antibody (5μg),
anti-RXRαantibody (5μg), controlmouse IgG (5μg), or control rabbit
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Fig. 3. Cellular localization of RXRα or PPARγ protein analyzed by immunohistochemistry and Western blotting. (A) HOZOT cells were stimulated with 1 μg/mL of anti-CD3/28
antibody for 16h and then treated with 1 μM TZD or NEt-3IP for 3h. For immunohistochemistry, cells were stained with rabbit anti-RXRα antibody (green) or mouse anti-PPARγ
antibody (green) and counterstained with Hoechst 33258 (blue). (B) HOZOT cells were stimulated with 1 μg/mL anti-CD3/28 antibody for 16h and then treated with 1 μM TZD
and/or NEt-3IP for 3h. Nuclear fraction was prepared and the subcellular localization of RXRα or PPARγ was determined by Western blotting. After stripping, the membrane was
reprobed with anti-acetyl-Histone H3 antibody. The optical density ratios of RXRα or PPARγ bands relative to corresponding acetyl-Histone H3 bands are shown for quantitative
analysis. Results of two independent experiments are presented as experiment 1 (left) and 2 (right). (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
IgG (5μg) at 4 ◦C overnight. Protein G beadswerewashed three times
with cold PBS and then chromatin extracts were incubated with Pro-
tein G beads at 4 ◦C overnight. After washing the immunoprecipitates
with washing buffer (Santa Cruz Biotechnology), DNA was eluted by
incubation with extraction buffer (Santa Cruz Biotechnology) at 67 ◦C
overnight. The DNA samples were puriﬁed and used as templates
for RT-qPCR. Bioinformatic analysis was performed using rVISTA. The
PPARγ response element (PPRE) of the double repeat (DR)1-type was
located in the IFN-γ promoter region at 493bp upstream of the IFN-G
transcription start site.
2.10. Statistical analysis
Statistical analysis was performed by one-way ANOVA, followed
by LSD post hoc test, with an acceptable signiﬁcance probability level
at <0.01 or <0.05.
3. Results
3.1. Expression proﬁles of NRs in HOZOT
In our previous studies, we characterized HOZOT by deﬁning the
cells’ cytokine signature [15] and found that two chemokines, RANTES
and IL-8, were produced at high levels by HOZOT.
To further analyze signature molecules, we focused on NR expres-
sion in HOZOT by comparing three conditions: unstimulated, ST2-
stimulated, and anti-CD3/CD28 antibody-stimulated. The results of
DNA microarray analysis are summarized in Table 1. We found that
19 NRs (RARA, PPARA, PPARB, PPARG, REV-ERBAA, REV-ERBAB, RORA,
RORG, LXRB, VDR, RXRA, RXRB, TR2, TR4, ERRA, GR, NGFIB, NURR1, and
NOR1) were expressed in HOZOT-4 among a total of human 48 NRs.
All of the expressed genes were categorized into two groups, either
inducible or constitutively expressed genes (Table 1). The inducible
genes, the expression of which was increased two- to 3347-fold by
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Table 1
Nineteen nuclear receptors expressed in HOZOT were detected by DNA microarray analysis.
Common name Symbol Genbank Fold change Raw data Flags
(-) ST2 CD3/28 (-) ST2 CD3/28 (-) ST2 CD3/28
Inducible
RARA NR1B1 AV657604 1 1.7 2.1 13.0 23.0 37.6 P P P
PPARG NR1C3 AK027107 1 2.3 15.9 7.1 17.0 155.8 A P P
REV-ERBAA NR1D1 X72631 1 2.6 12.9 9.7 26.6 172.2 A A P
REV-ERBAB NR1D2 AI761621 1 0.7 3.3 43.4 34.0 195.6 P P P
RORG NR1F3 AI218580 1 0.9 11.7 3.3 3.2 51.7 A A P
VDR NR1I1 AA772285 1 2.1 8.2 132.5 296.1 1504.2 P P P
ERRA NR3B1 L38487 1 1.3 2.0 71.3 95.7 196.5 P P P
GR NR3C1 AI432196 1 0.9 2.2 489.4 471.5 1501.1 P P P
NGFIB NR4A1 NM 002135 1 3.9 112.3 5.4 22.5 837.0 A P P
NURR1 NR4A2 NM 006186 1 2.6 247.3 11.3 30.9 3856.6 A P P
NOR1 NR4A3 U12767 1 1.5 3346.8 0.8 1.3 3693.9 A A P
Constitutive
LXRB NR1H2 NM 007121 1 1.1 1.7 76.3 88.4 175.9 P P P
PPARA NR1C1 AF086231 1 1.7 1.4 11.5 20.2 22.9 P P P
PPARB NR1C2 BC002715 1 1.0 0.9 17.2 18.2 20.3 P P M
RORA NR1F1 AK025371 1 0.8 0.4 31.7 25.9 17.6 P P P
RXRA NR2B1 NM 002957 1 1.3 0.7 53.6 71.2 55.3 P P P
RXRB NR2B2 BC001167 1 0.7 0.9 105.3 80.1 136.7 P P P
TR2 NR2C1 NM 003297 1 0.9 0.6 113.1 112.1 100.2 P P P
TR4 NR2C2 AL138444 1 1.1 0.5 346.3 394.2 228.9 P P P
anti-CD3/CD28 stimulation, included RARA, PPARG, REV-ERBAA, REV-
ERBAB, RORG, VDR, ERRA, GR, NGFIB, NURR1, and NOR1. The consti-
tutively expressed genes, the expression levels of which were less
than two-fold even after antibody stimulation, included LXRB, PPARA,
PPARB, RORA, RXRA, RXRB, TR2, and TR4.
3.2. High expression of RXRA and PPARG as candidate HOZOT markers
Next, we compared the expression of the NRs listed in Table 1
among different T cell subsets (HOZOT, nTreg cells, ConT cells, and
naı¨ve T cells) using RT-qPCR. HOZOT preferentially expressed ﬁve
NRs: PPARG, NGFIB, NURR1, NOR1, and RXRA (data not shown). To
validate the expression proﬁles of these NRs, we examined their ex-
pression by RT-qPCR using four sets of HOZOTs and three sets each
of ConT and nTreg cells. RXRA mRNA was highly expressed in three
of the four sets of HOZOTs and all three sets of Tregs cell lines com-
pared to the three sets of ConT cell lines, whereas the mRNA levels of
PPARG in HOZOTs (except for #14) and ConT cells (except for #3) was
higher than in Tregs (Fig. 1). On the other hand, the expression levels
of NGFIB, NURR1, and NOR1mRNA varied widely even among the four
sets of HOZOTs (data not shown). Therefore, we focused our interests
on RXRA and PPARG to explore the relevance of these NRs in HOZOT’s
characterization.
3.3. Time course of mRNA and protein expression of RXRA and PPARG
in HOZOT
As shown above, RXRA was constitutively expressed while PPARG
was inducible. Time course studies revealed in detail the cells’ ex-
pression at both mRNA and protein levels. Unstimulated HOZOT cells
expressed signiﬁcant levels of RXRαmRNAandprotein,whereas they
expressed low levels of PPARγmRNAandprotein (Fig. 2A andB). Even
after anti-CD3/CD28 antibody stimulation, RXRα expression did not
change much between 1.5 and 24h. In contrast, PPARγ expression
increased after antibody stimulation and reached a maximum after
3h (Fig. 2A). PPARg protein expression increased steadily upto 24h
after antibody stimulation (Fig. 2B). We conﬁrmed these properties
by ﬂow cytometric analysis (data not shown).
3.4. Subcellular localization of RXRα and PPARγ in HOZOT cells
To examine the subcellular localization of RXRα and PPARγ pro-
teins in HOZOT cells, we performed immunohistochemical analysis
and Western blotting analysis using nuclear extracts. RXRα protein
wasdetected in the cytoplasmunderbothanti-CD3/28antibody stim-
ulated and unstimulated conditions. On the other hand, PPARγ pro-
tein was weakly detected under unstimulated conditions, but upon
Ab stimulation, it appeared in the cytoplasm at high levels. When
treatedwith agonistic ligands for RXRα and PPARγ, NEt-3IP and TZD,
respectively, both RXRα and PPARγ proteins were translocated to
the nuclei (Fig. 3A). NEt-3IP is an agonist speciﬁc for RXRα/β but not
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Fig. 4. The suppressive effects of agonists or antagonists of RXRα or PPARγ on IFN-γ
production by HOZOT cells. IFN-γ production was measured by stimulating HOZOT
cells with 1 μg/mL anti-CD3/28 antibody for 16h. For the agonist and antagonist
treatment, HOZOT cells were pretreated for 30min with 0.1 and 1 μM NS-4TF (RXRα
antagonist) or GW9662 (PPARγ antagonist) and then treated with 0.1 and 1 μM NEt-
3IP or TZD. Culture supernatants were collected for determining IFN-γ levels by ELISA.
The values are shown as themeans± SD. Data are representative results of at least two
independent experiments. * p<0.01 compared with the values of the control without
ligand stimulation.
RXRγ, whereas TZD is speciﬁc for PPARγ but not PPARα/β. Western
blotting analysis conﬁrmed the localization of both NRs (Fig. 3B).
3.5. NEt-3IP and TZD inhibit IFN-γ production by HOZOT cells
To further investigate the functional relevanceofRXRαandPPARγ
proteins in HOZOT cells, we treated HOZOT cells with their agonis-
tic ligands and observed the effects on cytokine productions. HO-
ZOT cells produce high amounts of IFN-γ, RANTES, and IL-10. Among
them, IFN-γ production was inhibited in a dose-dependent manner
by either NEt-3IP or TZD treatment alone (Fig. 4). To examine an-
tagonist effects, we next treated HOZOT cells with combinations of
agonists and antagonists, namely RXRα agonist (NEt-3IP) plus an-
tagonist (NS-4TF) or PPARγ agonist (TZD) plus antagonist (GW9662).
Each antagonist abolished its corresponding agonist’s effects on IFN-
γ production (Fig. 4). In contrast, no signiﬁcant decrease or increase
in RANTES and IL-10 production was observed by NEt-3IP and TZD
treatment (Suppl. Fig. 2). Cell viability was maintained at high lev-
els at concentrations upto 10mM for both ligands (data not shown).
These results indicated that both NRs were functionally involved in
IFN-γ production in HOZOT cells.
3.6. PPARγ and RXRα directly bind to the IFN-γ gene
To explain the mechanism of suppression of IFN-γ production by
NEt-3IP and TZD in HOZOT cells, we hypothesized that RXRα and
PPARγ could directly bind to the IFN-γ promoter region. We ﬁrst
performed a bioinformatics search for DR1 and PPRE sites, speciﬁc
binding sequences for nuclear receptors, on the IFN-γ promoter re-
gionusingweb-based software, rVISTA.ADR1-typePPREwas found in
the IFN-γ promoter region at 493bp upstreamof the IFN-γ transcrip-
tion start site (Fig. 5). We next performed a ChIP analysis with anti-
RXRα antibody and anti-PPARγ antibody using HOZOT cells treated
with NEt-3IP or TZD. As shown in Fig. 6, low amounts of RXRα and
PPARγ proteins were bound to the IFN-γ promoter region, even in
ligand-unstimulated HOZOT cells. Upon ligand stimulation, increased
Fig. 5. Bioinformatics analysis of the PPRE/DR-1 region in the IFN-γ promoter region.
The sequence of the IFN-γ promoter region from – 810bp to 0bp. The PPRE/DR-1
sequence is underlined and marked red. Primers used for Chip-qPCR are marked with
black arrows. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
amounts of RXRα and PPARγ proteins were detected in Chip sam-
ples with speciﬁc antibodies but not in those with control antibodies.
These results supported our hypothesis that the inhibitory effects of
RXRα and PPARγ agonists on IFN-γ production operated through the
direct binding of these agonists to the IFN-γ promoter.
4. Discussion
Expression proﬁles of NRs during cell development and differenti-
ation have been reported by a number of investigators. For example,
Xie et al. [21] reported that ERRβ, DAX-1 and LRH-1 controlled the
development of embryonic stem cells. According to Barish et al. [22]
28 NRs including RXRα and PPARγ are involved in the activation
of macrophages. A number of NRs control T cell differentiation, for
example RORγt serving as a speciﬁc marker of Th17 cells. Thus, com-
prehensive analysis of NR expression in a new type of T cell, HOZOT,
was a necessary and interesting step to enhance our understanding
of this cell line. In this study, we found that 19 of 48 NRs were ex-
pressed in HOZOT, and identiﬁed eight genes (RXRA and TR2, etc.) that
were constitutively expressed, and 11 genes (NGFIB,NOR1,NURR1 and
PPARG, etc) that were inducible. Among them, RXRA and PPARGwere
selected for further analyses due to their more selective expression
patterns compared with other T cell subsets.
HOZOTs expressed both NRs at relatively high levels, whereas
Tregs showed the highest and the lowest expression of RXRα and
PPARγ, respectively. It is intriguing that the two NR expression pat-
terns were identiﬁed in T cell subsets, suggesting distinct functional
roles for these NRs in T cell biology. RXRα functions as a transcrip-
tion factor by forming a heterodimer complex with other NRs such as
PPARγ, VDR, LXRβ, RARα, and NURR1. Therefore, RXRα availability
determines the functionof theseNRs. It is noteworthy that the expres-
sion of RXRα remained unchanged after ST2 or T cell receptor stim-
ulation whereas the expression of PPARγ, VDR, RARα, and NURR1
was increased by stimulation. Given the fact that T-lymphocyte pro-
liferation and survival were diminished by RXRα disruption [23] and
that the anti-apoptotic gene Bcl2a1 was up-regulated by RXRα ago-
nist treatment [24], RXRα may play a central role by balancing the
availability for heterodimer formation with other NR partners. In this
regard, it will be interesting to elucidate how HOZOTs control het-
erodimer complex formation.
Since the in vivo counterpart of HOZOTs has not yet been identi-
ﬁed, the physiological relevance of high-level expression of RXRα and
PPARγ remains unclear. In general, RXR plays important regulatory
roles in metabolic disorders, such as type 2 diabetes, hyperlipiderma,
and atherosclerosis [25,26] and also in the control of innate inﬂam-
matory responses [27]. PPARγ possesses a broad range of biological
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Fig. 6. Chromatin immunoprecipitation analysis of RXRα or PPARγ binding to DR1/
PPRE. Cross-linked chromatin complexes from NEt-3IP-treated, TZD-treated or non-
treated HOZOT cells were immunoprecipitatedwith anti-RXRα, anti-PPARγ or control
IgG. ChIP-qPCR was performed using primers described in Fig. 5. Relative amounts of
the PCRproductwere normalized for those of corresponding input chromatin, and their
relative precipitationwas expressed as fold precipitation above the baseline. The values
are shown as the means± SD. Data are representative results of three independent
experiments. * p<0.01 compared with the values of control IgG.
activities in regulating lipid and glucose metabolism, and also nega-
tively modulating inﬂammation [28,29]. Anti-inﬂammatory roles of
these two NRs have been shown in conditional KO mice. Rxra KO
mice displayed elevated tumor necrosis factor-α and IFN-γ expres-
sion [23], whereas PPARγ KOmice exhibited elevated inducible nitric
oxide synthase and IFN-γ expression [29].
By in vitro functional studies, we demonstrated that both RXRα
and PPARγ agonistic ligands have inhibitory effects on IFN-γ produc-
tion by HOZOTs. PPARγ agonistic ligands exert inhibitory effects on
cytokineproductionbyT cells throughvariousmechanisms, including
inhibition of T cell activation, inhibited production of IL-2, induction
of apoptosis, inhibition of IL-12 production by antigen presenting
cell, or reduced IFN-γ production due to suppressed activation of c-
Jun [28,30–32]. In our system, it is interesting that either RXRα or
PPARγ ligand independently but not synergistically inhibited IFN-γ
production by HOZOTs (data not shown). To the best of our knowl-
edge, we demonstrated for the ﬁrst time that these inhibitory effects
were mediated through direct binding of these two NRs to the IFN-γ
promoter.
As previously discussed, RXR acts as both a homodimer as well as
a heterodimerwith PPARγ. Therefore, the next question is where and
how these dimers associate with DNA to control IFN-γ transcription
inHOZOT. The RXR homodimer interactswith a speciﬁc sequence, the
DR-1 element that is found on a variety of promoters or enhancers of
several distinct genes such as rat cellular retinol-binding protein type
II, human apo-A-I, human apo-A-II, and rat growth hormone [25].
Interestingly, the DR-1 element is also located in the IFN-γ promoter
region. Therefore, one possibility is that NEt3-IP exerts its inhibitory
effects on IFN-γ production by forcing RXR homodimer to bind to
IFN-γ’s DR-1 element. Another possibility is that RXRα heterodimer
binds to DNA and exerts its inhibitory effects, a phenomenon known
as a permissive effect. In this case, heterodimer partners could be
PPARγ or other NRs.
5. Conclusions
In conclusion, we found that RXRα and PPARγ were selectively
expressed in HOZOTs and can be used as signature NRs. We also
demonstrated that RXRα and PPARγ were functionally involved in
cytokine production inHOZOT cells. Furthermore, bothNRs repressed
IFN-γ gene expression via binding to the PPRE/DR1 element in HO-
ZOT cells. Our studies suggest a potential role for RXRα in the regula-
tion of inﬂammation and might provide a pharmacological approach
to modulating RXRα signaling as part of an overall strategy to sup-
press inﬂammation. Recently, Kakuta et al. [18] reported that type
2 diabetes was controlled in vivo by a treatment of NEt-3IP. Their
observation supports the speculation of our study.
Supplementary material
Supplementary material associated with this article can be found,
in the online version, at doi:10.1016/j.rinim.2012.08.001.
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